RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 11.25
0.00 (0.00%)
Sep 30, 2025, 3:55 PM GMT+1
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 6.98 million as of September 30, 2025. Its market cap has decreased by -10.00% in one year.
Market Cap
6.98M
Enterprise Value
4.54M
Revenue
4.11M
Ranking
n/a
PE Ratio
6,981.78
Stock Price
11.25
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 6.98M, a decrease of -70.69%. That is a compound annual growth rate of -4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 6.98M | 2.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | 33.72M | 127.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.94B |
| GSK plc | 61.10B |
| Haleon | 29.46B |
| Smith & Nephew | 11.41B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.76B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.55B |